Candel Therapeutics, Inc. (NASDAQ: CADL)

Sector: Healthcare Industry: Biotechnology CIK: 0001841387
Add ratio to table...

About

Candel Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of off-the-shelf viral immunotherapies for cancer treatment (Candel Therapeutics, Inc.). With no specific customer names provided in the text, the company operates in the biopharmaceutical industry, focusing on the development of viral immunotherapies to transform the lives of cancer patients. Candel Therapeutics' main business activities involve the creation of engineered viruses designed to induce a systemic anti-tumor response. This is achieved...

Read more

Statement of Income Location, Balance Breakdown of Revenue (2024)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VKTX Viking Therapeutics, Inc. - - - -
2 BOLT Bolt Biotherapeutics, Inc. - - - -
3 GERN Geron Corp - - - 119.55 Mn
4 VTVT vTv Therapeutics Inc. - - - -
5 DYAI Dyadic International Inc - - - -
6 VIR Vir Biotechnology, Inc. - - - -
7 NAMS NewAmsterdam Pharma Co N.V. - - - 57.27 Mn
8 RLYB Rallybio Corp - - - -